Tops & Flops Stocks
| Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Trevena Inc. | -2.500% | 4.520% | 9.145% | -75.911% | -39.444% | -98.869% | -98.909% |
| Trillium Therapeutics | - | - | - | - | - | - | - |
| Trinity Biotech ADR | -4.440% | - | - | - | - | - | - |
| Triple-S Management Corp | -1.250% | - | - | - | - | - | - |
| Trupanion Inc. | 4.470% | 24.424% | -3.165% | 3.846% | -16.545% | -63.032% | - |
| TSO3 Inc. | -0.740% | - | - | - | - | - | - |
| Twist Bioscience Corp | 0.330% | 2.796% | 32.771% | 227.560% | 13.897% | -50.403% | - |
| United Laboratories International Holdings Ltd | -1.750% | 7.692% | 3.704% | 46.405% | 41.772% | 68.421% | 134.310% |
| Universal Health Intl Group Holding Ltd | 100.000% | - | - | - | - | - | - |
| US Physical Therapy Inc. | -1.540% | 0.000% | -1.538% | -4.000% | 11.628% | -1.538% | -7.586% |
| Valneva SE | 2.700% | -4.400% | -13.316% | -39.406% | -29.839% | -72.070% | 0.030% |
| Vanda Pharmaceuticals | -1.280% | 3.540% | 17.588% | -17.895% | 20.619% | -65.839% | - |
| VBI Vaccines Inc. | -0.540% | 2.799% | -13.906% | -81.000% | 3.962% | -99.172% | -98.943% |
| Vectura plc | - | - | - | - | - | - | - |
| Veloxis Pharmaceuticals As | - | - | - | - | - | - | - |
| Veracyte Inc. | -0.530% | 0.529% | -0.524% | -9.524% | -26.357% | -45.714% | - |
| Verastem Inc. | 8.820% | 8.824% | 4.717% | 144.192% | 47.020% | -61.745% | - |
| Vericel Corp. | - | -1.351% | -3.947% | 46.980% | 35.185% | 4.286% | 181.563% |
| ViewRay Inc | 2400.000% | - | - | - | - | - | - |
| Viking Therapeutics Inc | -7.140% | -4.337% | 2.549% | 230.818% | 291.078% | 1342.616% | - |
| Viracta Therapeutics Inc. | -0.670% | 0.000% | -26.238% | -26.961% | 50.810% | -91.286% | -98.194% |
| Virbac S.A. | 1.300% | 1.004% | 0.285% | 20.548% | -1.950% | 32.830% | 115.422% |
| Virtus Health Ltd | - | - | - | - | - | - | - |
| Vita 34 AG | 0.430% | -2.929% | 0.870% | -34.831% | -11.450% | -73.256% | -67.666% |
| Vitrolife AB | 0.460% | 1.325% | -6.081% | -26.278% | -13.811% | - | - |